Work

Preliminary Results from an Ongoing Phase 1/2 Study of INCB053914, a Pan-Proviral Integration Sites for Moloney Virus (PIM) Kinase Inhibitor, in Patients with Advanced Hematologic Malignancies

Year: 2017

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v130.suppl_1.2585.2585

Authors: Michael Byrne, William B. Donnellan, Manish R. Patel, Amer M. Zeidan, Mohamad Cherry, Maria R. Baer, Amir T. Fathi, Jason Kaplan, Feng Zhou, Fred Zheng, April Barbour, Michael R. Savona

Institutions: Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Tennessee Oncology, Yale Cancer Center, Yale University, OU Health, OU Health Stephenson Cancer Center, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Harvard University, Massachusetts General Hospital, Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Incyte (United States)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3035503703

FWCI: 0.843

Cites:

Cited by: 8

Related to: 10